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Abstract
Background: Current concepts in conservative dentistry advocate minimally invasive dentistry and pulp vitality
preservation. Moreover, complete removal of carious dentin in deep carious lesions often leads to pulp exposure
and root canal treatment, despite the absence of irreversible pulp inflammation. For years, partial caries removal has
been performed on primary teeth, but little evidence supports its effectiveness for permanent teeth. Furthermore,
the recent development of new antibacterial adhesive systems could be interesting in the treatment of such
lesions. The objectives of this study are to compare the effectiveness of partial versus complete carious dentin
removal in deep lesions (primary objective) and the use of an antibacterial versus a traditional two-step self-etch
adhesive system (main secondary objective).
Methods/Design: The DEep CAries Treatment (DECAT) study protocol is a multicenter, randomized, controlled
superiority trial comparing partial versus complete caries removal followed by adhesive restoration. The minimum
sample size required is 464 patients. Two successive randomizations will be performed (allocation ratio 1:1): the first
for the type of excavation (partial versus complete) and the second (if no root canal treatment is required) for the
type of adhesive (antibacterial versus traditional). For the two objectives, the outcome is the success of the
treatment after 1 year, measured according to a composite outcome of five FDI criteria: material fracture and
retention, marginal adaptation, radiographic examination (including apical pathologies), postoperative sensitivity
and tooth vitality, and carious lesion recurrence.
Discussion: The study will investigate the interest of a conservative approach for the management of deep carious
lesions in terms of dentin excavation and bioactive adhesive systems. The results may help practitioners achieve the
most efficient restorative procedure to maintain pulp vitality and increase the restoration longevity.
Trial registration: ClinicalTrials.gov Identifier NCT02286388. Registered in November 2014.
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Background
Currently, caries management should be based on
minimal intervention dentistry concepts [1], including
minimally invasive cavity preparations when surgical
intervention is required. However, with deep carious le-
sions, the most commonly used procedure is complete
excavation in one step, with hardness to a dental probe
used to assess caries excavation [2, 3]. This practice
leads to a high risk of pulp exposure and poor progno-
sis in terms of maintaining pulp vitality [4].
Two alternative options have been proposed to
minimize the risks of pulp exposure and postoperative
pulpal complications.
The first strategy, chronologically, is the stepwise tech-
nique (complete excavation in two steps), with residual
carious dentin at the pulpal wall of the prepared cavity
left under a temporary restoration placed at the first visit
followed by a complete excavation at a second visit (gen-
erally 2–6 months later). Clinical surveys have compared
the stepwise technique with one-step complete excava-
tion in permanent teeth [5, 6], primary teeth [7], and
mixed dentition [8]. Nevertheless, the stepwise technique
is time-consuming and costly, and pulp exposure occurs
in 15–20 % of cases during the second excavation step [9].
The second approach, more controversial due to a
paradigm shift, is partial (incomplete/selective) excava-
tion. The clinical procedure is the same as with the step-
wise excavation but without any second procedure. To
avoid pulp exposure, carious dentin remains close to the
pulp and the cavity is sealed with a definitive restoration.
This concept is based on substantial evidence that re-
moval of all carious dentin in deep carious lesions is not
required for successful lesion management, provided
that the restoration can effectively seal the lesion from
the oral environment [10]. Studies have compared step-
wise with partial excavation techniques only in perman-
ent teeth [11, 12] or complete excavation in one step
with partial excavation essentially in primary teeth
[13–17] and mixed dentition [8]. Partial excavation re-
sults in lower long-term costs, longer-retained teeth
and better pulp preservation than complete excavation
(in one or two steps). However, because of high risk of
bias within studies, more randomized clinical trials are
needed for definitive conclusions [9, 18, 19].
Two multicenter randomized clinical trials are cur-
rently ongoing, one comparing selective and stepwise ex-
cavation of deep carious lesions in primary molars [20]
and our study comparing complete excavation in one
step to partial excavation in permanent teeth.
Furthermore, after dentine excavation, different ma-
terials may be used to restore the loss of tooth
substance [21]. Glass ionomer cements (GIC) are
commonly used because of their biocompatibility,
fluoride release and adhesive properties, but they
have weak mechanical and aesthetic properties [22].
Dental composite resins have high mechanical and
good aesthetic properties but limited bioactive prop-
erties [23] and require a specific adhesive system.
Few clinical studies have evaluated the role of anti-
microbial agents incorporated into restorative mate-
rials and their potential anti-caries effect [24]. An
effective bactericidal effect from adhesive systems
could be an alternative to suppress residual contam-
ination after caries removal [25], even more so with
incomplete eviction. Adhesive systems usually have
limited bioactivity. A new adhesive, Clearfil™ SE Pro-
tect (Kuraray Europe Gmbh, Hattersheim, Germany),
is the only adhesive system considered to have anti-
bacterial properties. This adhesive system contains 12-
methacryloyloxydodecylpyridinium bromide (MDPB),
which inhibits the proliferation of bacteria involved in
dentinal caries like Streptococcus mutans, Lactobacillus
casei and Actinomyces naeslundii and reduces lactic acid
production of S. mutans [26–30]. Moreover, it has been
shown that, in vivo, this adhesive system can induce the
inhibition of caries progression [31] and preservation of
pulp vitality [32].
However, no clinical study has evaluated this type of ad-
hesive for conservative treatment of deep carious lesions.
Objectives and hypotheses
The aim of this clinical trial is to support a management
strategy that preserves pulp vitality in cases of deep cari-
ous lesions with partial caries removal, followed by a
composite restoration, in a single session.
The primary objective is the comparison of the efficacy
(binary success criteria) of partial (P) versus complete
(C) excavation in deep carious lesions of mature per-
manent teeth at 1 year. The main secondary objective is
the efficacy (binary success criteria) of an antibacterial
adhesive (AA) versus a traditional two-step self-etch ad-
hesive (TA) at 1 year. Two secondary objectives will be
also considered: (i) the identification of predictive factors
for success at 1, 2, and 3 years and (ii) the description of
the consequences of treatment failure and side effects
for each treatment arm.
The underlying pathophysiological hypotheses are that
(1) partial excavation would imply less irreversible pulp
diseases as compared with complete excavation in one




The Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) guidelines [33] have strictly been
followed in the planning of this trial (Additional file 1).
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This trial is a multicenter intention-to-treat randomized
controlled superiority trial with parallel arms. Analysis of
results will be performed according to the intention-to-
treat principle. For the primary objective, only patients are
blinded to the allocated intervention (partial or complete
caries removal). For the secondary objective (type of adhe-
sive), both patients and investigators are blinded. Out-
come examiners and data analysts are always blinded.
Two successive randomizations are performed (alloca-
tion ratio 1:1): first, for the type of excavation (P versus C)
and second, for the adhesive system (AA) versus TA. The
second randomization is not performed for teeth requiring
endodontic treatment after the first randomization.
The possible combinations of interventions are in
Fig. 1, the flow diagram is mentioned on Table 1 and the
flow chart of the study is in Fig. 2.
Setting and participants
This study is being carried out in 13 academic hospitals
and two private practices in France (study sites can be
found at ClinicalTrials.gov; inclusion from February
2015 to July 2016).
Eligible patients, and their parent(s), if necessary, re-
ceive the study information. Informed consent forms are
given to the patient and to the parent(s) of minor pa-
tients (age 8–18 years), before inclusion.
To be included in the trial, patients must 8–80 years
old, able to receive dental care, covered under the na-
tional health coverage system, and have a mature per-
manent posterior tooth affected by a deep carious
lesion. The tooth should have normal response to pulp
sensitivity tests, without periapical pathology, and re-
quire direct restorative procedure. Exclusion criteria
are not French-speaking, under guardianship or preg-
nant, have a pacemaker, or at risk of infectious endocar-
ditis. Other exclusion criteria are severe periodontal
disease (axial or high lateral mobility and/or pocket
depth more than 5 mm), poor oral hygiene (patient
with abundant plaque, i.e., plaque index = 3 according
Silness and Loe plaque index) and allergy to any
Fig. 1 Combinations of interventions
Table 1 Flow diagram
Study period
Selection visit Randomization visit Postrandomization visit Emergency visit
Time point T-1 T0 T0 + 1 yr T0 + 2 yrs T0 + 3 yrs Between T0 and T0 + 3 yrs
Enrolment:
- eligibility screen X
- informed consent X
- randomization X
Interventions:
- caries management X If needed
- X-ray X X X X X If needed
Control of carious eviction with the SoproLife® X
assessment:
- baseline variables X X
- FDI criteria X X X X
- other data variables listed in the CRF X X X X
FDI FDI World Dental Federation, CRF case report form
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component of the materials used in the procedure.
Teeth with excessive wear, carious cervical lesion, ex-
ternal or internal resorptions, or abutment for remov-
able partial denture are not eligible. Exclusion criteria
have been chosen to reduce loss of follow-up or modifi-
cations independent of the treatments studied.
Medications (painkillers, non-steroidal anti-inflammatory
drugs) taken less than 8 days before or during the study
must be reported.
No special concomitant care or intervention is prohib-
ited after inclusion in the trial, except that concerning
the included tooth.
Sample size
According to a literature review [9, 34–42], 97 % and 90 %
of success is expected for P and C dentin excavation
strategies, respectively. A total of at least 464 patients
would be needed for a bilateral test with an alpha risk of 5
% and a power greater than 80 %, supposing at 1 year 10
% of patients lost to follow-up as a ‘not to exceed’ value
(calculated by nQuery Advisor 7.0) [43–45].
With the expected recruitment of each investigator, in
order to reach the target sample size and respect the in-
clusion period of 18 months, this trial involves 15 cen-
ters. To encourage recruitment, the main investigator
sends an encouraging text message after each inclusion
and the center recruitment appears on the main page of
the randomization website.
Randomization
Randomization is performed using a computerized and
centralized system via a specific website. A two-stage
Fig. 2 Flow chart
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randomization process allows for integrating the two
levels of randomization (i.e., the type of excavation and
the nature of the adhesive). A minimization procedure is
implemented to take into account the following prognos-
tic characteristics: investigator, patient age (by age group),
type of carious lesion (primary or secondary), location of
the lesion (proximal or occlusal) and pulp exposure.
Because all patient and cavity characteristics must be en-
tered in the electronic case report form (eCRF) before in-
terventions are assigned, sequence concealment is secured.
Implementation
The minimization algorithm was implemented by stat-
isticians and methodologists independently of investiga-
tors. Patients are assigned to interventions arm by the
investigators.
Intervention
At the first visit, eligibility criteria are verified by an in-
vestigator. Information about the study is then given to
the patient and the inclusion is formalized by the signing
of the informed consent form.
A clinical examination is performed, then (1) pulp vi-
tality is assessed with thermal (cold) and electrical
methods (Elements Diagnostic Unit and Apex Locator®,
Kerr Endodontique, Bioggio, Switzerland); and (2) bite-
wing and retroalveolar radiographs are taken by using
film-holders supplied by Kerr Endodontique. Bite-wing
radiographs allow for assessing the depth of the lesion:
no continuity between the carious lesion and the pulp
chamber should be seen; and retroalveolar radiographs
allow for determining the periapical index [46]. In case
of multiple carious lesions, the lesion that best meets the
inclusion criteria and allows for the best handling (easy
access) is chosen. Other lesions will be further treated
according to usual procedures and will not be entered in
the study.
At the second visit, an investigator performs the tooth
restoration. The tooth is anesthetized. The shade of the
tooth-colored restoration is selected before isolation
with the rubber dam. The first randomization is
achieved. The superficial necrotic tissues and peripheral
demineralized dentin are removed with complete exca-
vation to avoid excavation close to the pulp. The bulk of
the carious dentin is removed by using sterile round cer-
amic burs (Komet France, Paris, France) under water
spray cooling and the final excavation with hand instru-
ments. The excavation is controlled by use of an
intraoral light-induced fluorescence camera (Soprolife®,
Acteon Group, La Ciotat, France) and the corresponding
image is registered. According to the manufacturer of
the Soprolife® camera, infected carious tissues appear
green-black in fluorescence. The infected/affected dentin
interface emits bright red fluorescence in active lesions
and dark red fluorescence in arrested lesions. The
underlying dentin looks gray-green in fluorescence [47].
For cases under P excavation, the investigator stops
excavating when the dentin close to the pulp appears
bright or dark red after removal of the green-black in-
fected dentin.
For cases under C excavation, the investigator stops
excavating when the dentin close to the pulp appears
gray-green after removal of the green-black infected
dentin and removal of the bright or dark red infected/
affected dentin interface.
With pulp exposure < 2 mm2 after C excavation, the
exposed pulp is irrigated with chlorhexidine. Following
hemostasis (within 5 minutes), a tricalcium silicate ce-
ment (Biodentine™, Septodont, Saint Maur des Fossées,
France) is applied according to the manufacturer’s in-
structions. After complete cement setting (within 15
minutes), the cavity is restored following the same clin-
ical procedures as for cases without pulp exposure.
With pulp exposure > 2 mm2 and/or no hemostasis, a
root canal treatment is performed, and the case is consid-
ered a failure for randomization 1 but not randomization 2.
Cases undergo randomization 2 to determine the ad-
hesive system: Clearfil™ SE Bond (Kuraray Europe) or
Clearfil™ SE Protect (Kuraray Europe) (i.e., TA and AA,
respectively). Enamel and dentin are prepared according
to the manufacturer’s instructions. The tooth is restored
by using the Gradia® Direct Flo and Gradia® Direct
Posterior composite resin (GC Europe N.V., Leuven,
Belgium) in accordance with the manufacturer’s instruc-
tions and if necessary a matrix system (Kerr Restaura-
tion, Bioggio, Switzerland). The photo-polymerization
steps involve use of a LED curing light (Demi™ Ultra,
Kerr Restauration, Bioggio, Switzerland). Then, a bite-
wing radiograph is taken as a control.
Various strategies are implemented to improve adher-
ence to intervention protocols: the investigator must
submit the fluorescence image obtained after caries
removal as well as the control radiograph to the
randomization website. He must also indicate the adhe-
sive applied.
Outcome measures
Cases are considered successful if each of the following
five FDI World Dental Federation (FDI) criteria has a
final score ≤ 3: material fracture and retention, marginal
adaptation, radiographic examination (including apical
pathologies), postoperative sensitivity and tooth vitality,
and recurrence of carious lesions [48, 49]. A score of 4
or 5 indicates that reintervention is necessary and, there-
fore, the case is classified as a failure in the context of
the study. Criteria are scored at 1, 2, and 3 years’ postin-
tervention by two blinded independent trained evalua-
tors. Study assessing the agreement between evaluators
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for FDI criteria is ongoing. In cases of emergency visits,
FDI criteria will be scored by the investigator.
For the primary objective (P versus C excavation) and
the main secondary objective (AA versus TA), the out-
come will be the success (yes/no) at 1 year, as defined
previously.
For the first secondary objective (identification of
factors predicting success at 1 and 3 years), the following
candidate factors will be investigated: postoperative pain,
patient age, type of carious lesion (primary or second-
ary), location of the carious lesion, and pulp exposure.
For the second secondary objective (description of the
consequences of treatment failure and side effects per
treatment arm), the following events will be considered:
total number of needed visits, number of endodontic
treatments, and number of avulsions.
Data collection methods
Trial data are collected in an eCRF. To promote data
quality, investigators, and evaluators (examiners), who
will assign scores, are trained in the FDI criteria by
means of the e-calib web-based software (www.e-cali-
b.info) and group training sessions. Two independent
evaluators will perform the follow-up examinations. If
disagreements occur during the evaluations, evaluators
will have to reach consensus. Data collection forms can
be found in the trial protocol as well as on the
randomization website. To promote participant reten-
tion and complete follow-up, each patient will receive 90
€ on completion of the trial as compensation for attend-
ing the follow-up appointments.
Data management
Data are entered by investigators and evaluators on the
eCRF. Fields include range checks for data values. Fields
cannot be left blank.
Interactive data controls will be applied for value
ranges and presence of and between-form coherence.
Data will be kept anonymous, with high-level security
storage, with encryption of all data transfers, in compli-
ance with French regulatory and European Clinical Re-
search Infrastructure Network (ECRIN) requirements.
Statistical methods
The statistical unit for analysis will be the tooth. Only
one tooth per patient will be included and treated ac-
cording to the protocol. The demographic and clinical
characteristics of patients and treated teeth will be de-
scribed for both treatment arms with mean and SD or
median and interquartile ranges for quantitative vari-
ables and number of subjects, and percentages for quali-
tative variables. The analyses will be performed according
to the intention-to-treat principle.
To evaluate the primary objective, the probability of
success in arms P and C at 1 year will be calculated and
compared by Fisher’s exact test. The probability of suc-
cess for each arm (0 for treatment failure and 1 for suc-
cess, at 1 year) will be assessed by a hierarchical logistic
model. This model accounts for the correlation related
to the hierarchical structure of the data (several patients
treated by one practitioner) as well as any possible inter-
practitioner heterogeneity. The model will be adjusted
on the type of adhesive (arm AA or TA) and on prog-
nostic factors accounted for in the minimization scheme.
If necessary, other adjustment factors might also be con-
sidered. In cases of patient non-compliance with follow-
up visits, the last investigator’s assessment will be used
in the analysis, if there is one.
All analyses related to the primary objective (Fisher’s
exact test and the modeling approach) will initially in-
clude all patients with an available primary outcome as
modified ITT. The number of patients to be included
has been increased to account for missing outcomes.
Then, three sensitivity analyses will be performed: the
first according to the maximal bias approach (missing
data considered as “success” in arm C and as “failure” in
arm P), the second considering all missing data as
successes, and the third considering all missing data as
failures.
For the secondary objectives comparing efficacy (as
defined for the primary objective) at 1, 2, and 3 years
and between arm AA and arm TA at the three different
times, similar analyses to those used for the primary
objective will be performed. The probability of success
for each criterion will be assessed and compared
between arms by using the hierarchical logistic model
described previously.
Candidate factors for subgroup analyses are patient
age, type of carious lesion (primary or secondary), caries
risk, lesion location, and pulp exposure. Subgroup ana-
lyses will be performed globally, then stratified by type
of removal (C and P) and adhesive (AA and TA). In the
model analysis, the interaction between a specific factor
and the type of removal (arms C versus P) or the adhe-
sive used (arms AA versus TA) will also be considered
by its clinical relevance and in the descriptive analyses.
The consequences of failure and side effects between
arms will be assessed by a descriptive approach (range,
median, and quartiles for quantitative variables, number
and percentage for qualitative variables).
Data monitoring, harms and auditing
The data will be monitored by an independent clinical
research assistant, who will compare the data entered in
the eCRF with those in the patient’s paper clinical rec-
ord. In case of disagreement, the patient’s investigator
will be asked to clarify the data. No interim analysis
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(other than that described above) is planned. If possible,
the follow-up duration will be extended. Concerning
harm monitoring, specific adverse events forms can be
accessed in the eCRF. Trial management may be audited
by the French Department of Health at any time; the
audit would be independent of investigators and the
sponsor. Investigators will not have access to the final
trial data set; the latter will be accessed by clinical re-
search assistants, data managers, and statisticians only.
Ethical consideration
The Human Research Ethics Committee of the University
Hospital of Lyon (Comité de protection des personnes or
CPP Sud-Est IV) has approved the study protocol (2014-
A00907-40). The protocol is registered with the Agence
Nationale pour la Sécurité du Médicament et des Produits
de Santé (ANSM, the French National Agency for Medi-
cines and Health Products Safety; no. 2014-A00907-40)
and ClinicalTrials.gov (no. NCT02286388). All amend-
ments to the protocol will be justified, submitted to the
scientific board, accepted by the CPP Sud-Est IV and re-
corded by the ANSM. Changes and amendments will be
also recorded at ClinicalTrials.gov. Informed consent
will be obtained from trial participants or authorized
surrogates (parents of children aged 8–18) after trial
explanation by an investigator or investigator of the
corresponding center. Patients are informed that they
have the right to withdraw from the study at any time
without giving reasons. Regardless of withdrawal, pa-
tients will be provided any treatment in their best inter-
est. Withdrawal will be documented. Data confidentiality
was audited by the Comité National Informatique et Lib-
erté (CNIL, National Committee of Informatics and Free-
dom); last and first names of included patients are not
recorded in the database.
No Data Monitoring Committee is needed for a DEep
CAries Treatment (DECAT) study as no or very few
serious events are expected from this study limited to
common dental care. No interim analyses are planned.
Dissemination of results
The Consolidated Standards of Reporting Trials (CON-
SORT) guidelines will be used to report the results of
this study and the results will be published in inter-
national peer-reviewed journals [50]. Authors of the
publications will be people involved in the elaboration of
protocol, the implementation and conduct of the trial,
and the writing of the manuscript and report. The re-
sults related to the main objective will be authored by
the coordinator, the methodologists, the investigators who
have included at least 15 cases and other people who will
have significantly contributed to the planning of the trial,
its implementation, or the writing of the report.
A summary of the study results will be posted at
ClinicalTrials.gov to allow general access to the findings.
Data sharing will be at the participant level. Access to
the full protocol can be granted to anyone upon request.
The database will be open after the main analysis to
the academic community including meta-analyses on
individual data
Discussion
An alternative to the usual care for caries lesion removal
would be more widely adopted by both clinicians and
policy makers if the evidence showed that the more con-
servative partial excavation technique was at least equally
successful, less time-consuming, and more cost-effective
than the complete excavation procedure. However, a high
level of evidence is lacking [18, 19]. The systematic review
by Bergenholtz et al., in 2013, found that only a few stud-
ies have examined partial caries removal and that the sam-
ple size was often fewer than 100 patients [18]. This trial
may help address this issue well because it involves 13
centers nationwide, and the recruitment of a minimum of
464 patients should be possible. Two private dental prac-
tices are also involved because the patient profiles in pub-
lic consultation may differ from those in private dental
practices. In addition, the inclusion criteria are broad, so
patients included are varied, especially in terms of individ-
ual caries risk. Hence, the external validity of the data
should be optimized.
In addition, this study will provide new insights into
the use of antibacterial adhesive systems. Currently, to
our knowledge, only one antibacterial adhesive system is
available on the professional market (Clearfil™ SE Pro-
tect). The adhesive selected as the reference in this trial
is similar to Clearfil™ SE Protect except for the antibac-
terial component to allow evaluating the interest of
adding antibacterial components to adhesive resins.
All current recommendations (the SPIRIT statement)
were taken into account for the design of the present
clinical trial [33]. A complete factorial design would have
allowed for exploring the interaction between the
management strategies (P versus C excavation, and AA
versus TA). However, the impossibility of randomizing
the adhesive with endodontic treatment, expected to be
more frequent with C excavation, led us to adopt a
nested design with two distinct and successive randomi-
zations. The tooth was chosen as the statistical unit,
with only one tooth per patient, to ensure the independ-
ence between statistical units. If a split-mouth design
had been chosen, finding patients with two cavities simi-
lar in depth would have been difficult. In terms of in-
ternal validity, the sources of bias are limited by the use
of centralized randomization (selection bias), strict pro-
spective data record and monitoring (information bias),
and blinded patients and evaluators (performance and
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detection bias). However, because of the nature of the
investigation, the investigators cannot be blinded.
The choice of assessment criteria is based on the 16
criteria for evaluating direct restorations published and
approved by the FDI [48]. As suggested by Hickel et al.,
a selection of criteria was chosen to match the objectives
of the study [49]. The focus was functional properties
(material fracture and retention, marginal adaptation,
radiographic examination) and biological properties
(postoperative pain and tooth vitality, recurrence of cari-
ous lesions).
The clinical procedure is carried out under optimal
conditions. One of the main points is that partial re-
moval involves only the tissues close to the dental pulp.
Indeed, the cavity margins should include no carious tis-
sue so as to avoid the recurrence of the lesion at the
tooth-restoration interface. Decay can reach different
surfaces of the tooth, but the restoration must be single
and unique to avoid any confusion during the evaluation
step. For the same reason, the included tooth must be
free of cervical carious lesion.
The present research focuses on indications and out-
comes of interventions including the use of dental mate-
rials. The availability of new data should help educate
decision makers in the dental profession and play a
major role in planning evidence-based dental treatment.
The results will allow for advancement toward minimum
intervention in general as well as minimally invasive
dentistry, beneficial for the patient, the practitioner, and
the public health care system.
Trial status
The trial is currently in the recruitment phase.
Additional file
Additional file 1: SPIRIT checklist of the trial. (DOC 133 KB)
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